Lurasidone
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 844 publications
Bipolar major depression: A comprehensive review of pharmacotherapy.
Journal: The Nurse practitioner
Published: January 22, 2026
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy.
Journal: Healthcare (Basel, Switzerland)
Published: November 12, 2025
Treatment of depressive episodes with mixed features: A systematic review and meta-analysis.
Journal: General hospital psychiatry
Published: October 28, 2025
Identification of N-Debenzisothiazole-Lurasidone as an Enzymatic Degradation Product of Lurasidone.
Journal: Journal of analytical toxicology
Published: October 24, 2025
Balancing Mental Health and Breastfeeding: Evaluating the Transfer of Lurasidone Into Human Milk.
Journal: The Journal of clinical psychiatry
Published: October 23, 2025
Bipolar disorder in children, adolescents and young adults. Part 2. Therapeutic management. Recommendations under the patronage of the Executive Board of the Polish Psychiatric Association, National Consultants in the field of Psychiatry and National Consultants in Child and Adolescent Psychiatry.
Journal: Psychiatria polska
Published: October 22, 2025
Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review and meta-analysis of randomised controlled trials: commentary, Chen et al.
Journal: The British journal of psychiatry : the journal of mental science
Published: October 17, 2025
Cutaneous Pseudolymphomas of the Scalp Secondary to Lamotrigine.
Journal: Cureus
Published: October 08, 2025
Relationship between the Montgomery-Åsberg Depression Rating Scale and Sheehan Disability Scale in patients with bipolar depressive episodes.
Journal: International journal of psychiatry in clinical practice
Published: September 22, 2025
Aripiprazole- and Lurasidone-Induced Akathisia: A Case Report and Literature Review.
Journal: Cureus
Published: September 18, 2025
Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 08, 2025
Lurasidone and Fluvoxamine Combination in Eating Disorders with Comorbid Obsessive-Compulsive Disorder: Preliminary Evidence from an Observational Study.
Journal: Medical sciences (Basel, Switzerland)
Published: September 02, 2025
Last Updated: 02/24/2026